Testimonials From Accounting Implications of Pharma Licensing Deals for BD&L Managers

Michelle gave a nice explanation of financial statements and their impact on the licensing deals and an interesting insight into materiality thresholds. She helped us to better understand key accounting principles during a business negotiation. She also gave us great opportunities to exchange some work experiences with other professionals and share issues we are facing during our daily jobs through the active discussions during the case studies. Overall I am really glad I attended this course, thank you everyone!

Menarini

Federica Fontani, Corporate Alliance Manager - Italy - November 2021 (live online course)
I really enjoyed the varied content and practical examples to reinforce theory during this training. The service and communication from CELforPharma was great! They sent the pre-reading before the course which was useful context before attending on the day. Also, I found the online format of this training worked really well. Thanks so much for a valuable 1 day training.

Kyowa Kirin

Lois Paton, Business Development Manager - United Kingdom - November 2021 (live online course)
I would definitely recommend this course as it is a very good BD pharma course for someone who wants to understand better the accounting treatment. Many thanks!

Ferring

Marco Zevenboom, VP Finance Accounting & Reporting - Switzerland - November 2021 (live online course)
Michelle is an extraordinarily knowledgeable instructor who takes care to address the key concerns each participant brings to her course. She is very structured in her approach, clear in her answers, and takes participants' various backgrounds into account. I highly recommend her course to anyone grappling with the accounting implications of BD&L deals in the pharmaceutical industry!

Boehringer Ingelheim

Ryan Rickards, Finance Manager Controlling - United States - November 2021 (live online course)
A very well-run, interactive course with just the right level of detail for Business Development people.

Kyowa Kirin

Chloe Anderson, Global Alliance Officer - United Kingdom - June 2021 (live online course)
Everything for this course was great! I learned so much in 1 day, from calculating probabilities to differentiating accounts and payments. I now clearly know what to capitalise and what to expense thanks to the expert trainer Michelle. Not only did I learn a lot from the expert, but also from the other people attending the course during the group discussions. It was interesting to find out about others experiences. Thank you very much CELforPharma!

Servier

Tatiana Kamel, Alliance Project Leader - Russian Federation - June 2021 (live online course)
The course improved my perspective from an accounting view point for the next time I negotiate an agreement. I got to discuss my specific questions and examples with the expert, who was highly competent, and at the end of the day I had a much better understanding of the topic of accounting implications of licensing deals. Overall, a very good course that worked well in a virtual setting. Thanks!

LEO Pharma

Tero Wennberg, Business Development Director - Denmark - June 2021 (live online course)
This was a very interesting course and I learned a lot. Michelle is a very skilled trainer!

Boehringer Ingelheim

Frerich de Vries, Global Head Business Development and Licensing Animal Health - Germany - November 2020 (live online course)
High quality course that met my expectations thanks to the quality of the lecturer as well as the prepared course materials and the good organisation. Perfect base to start to learn more about license and cooperation deals from an accounting and tax perspective.

Sotio

Marie Kučerová, Head of Finance, Tax, Accounting - Czech Republic - November 2020 (live online course)